The brokerage's cautious stance comes after Dr Reddy's disclosed that it had temporarily suspended commercial supplies of Semaglutide injections following the identification of an out-of-specification impurity during the API scale-up validation process
The brokerage's cautious stance comes after Dr Reddy's disclosed that it had temporarily suspended commercial supplies of Semaglutide injections following the identification of an out-of-specification impurity during the API scale-up validation process
<iframe src="https://hindustansphere.com/embed/cluster/941b3319f0c94d2f33078cf6aee5c97ed13c596f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Dr. Reddy's Downgraded By Systematix After Semaglutide Setback; Target Price Cut — Should You Buy Or Hold?"></iframe>
